Montelukast BE study - Cmax shows supra bioavailability [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2016-12-01 14:56 (3033 d 05:38 ago) – Posting: # 16820
Views: 10,013

Hi
Montelukast is rapidly absorbed following oral administration. For the 10 mg film-coated tablet the mean oral bioavailability is 64%. For the 5 mg chewable tablet, the mean oral bioavailability is 73% and is decreased to 63% by a standard meal.

So, no BCS class I substance (BA < 85%). But even if it would be a BCS class I substance you have the results of the BE study and you can not ignore this.

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,669 registered users;
21 visitors (0 registered, 21 guests [including 3 identified bots]).
Forum time: 20:34 CET (Europe/Vienna)

Facts are meaningless. You could use facts to prove
anything that’s even remotely true!    Homer Simpson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5